How to incorporate equity indicators in randomized controlled trials?
On September 22nd and 23rd, researchers from Global Health Priorities and Centre for Intervention Science in Maternal and Child Health (CISMAC) co-organized a symposium at Harvard T.H. Chan School of Public Health in Boston (USA) on how to incorporate concerns to health equity into randomized control trials (RCTs).
While concerns to equity, inequality and distribution of health and welfare outcomes have received attention in policy agendas worldwide, little guidance has been provided guidance on how to incorporate concerns to health equity into RCTs. During the two day symposium 25 researchers and experts discussed how intervention science can improve equity in health going beyond the traditional RCTs. Furthermore, how to design, power, measure, and analyze equity impact in RCTs? The outcomes of the symposium will be presented in peer-reviewed publications and development of Reporting guidelines for equity-relevant RCTs.
The symposium was co-led by the Centre for Intervention Science in Maternal and Child Health (CISMAC, University of Bergen), the Campbell and Cochrane Equity Methods Group (University of Ottawa) and the University of York Centre for Health Economics.
From CISMAC professor Ole F. Norheim, Professor Halvor Sommerfeldt, Professor Bjarne Robberstad and Associate Professor Kjell Arne Johansson contributed to the symposium.
From the Global Health Priorities research group members Professor Ole F. Norheim, Professor Bjarne Robberstad, Associate Professor Kjell Arne Johansson, Associate Professor Kristine Bærøe, and Post doc Gry Wester contributed. Norheim and Johansson work primarely in the GHP research group, while Robberstad mainly work at CISMAC.